Osteopenia: a common aspect of Fabry disease. Predictors of bone mineral density. - Wikidata - wikimedia - TriplyDB

Osteopenia: a common aspect of Fabry disease. Predictors of bone mineral density.

Osteopenia: a common aspect of Fabry disease. Predictors of bone mineral density.

http://www.wikidata.org/entity/Q46842600

about

Skeletal manifestations in pediatric and adult patients with Niemann Pick disease type B.Antiepileptic medications increase osteoporosis risk in male fabry patients: bone mineral density in an Australian cohort.Positron Emission Tomography and Magnetic Resonance Imaging of the Brain in Fabry Disease: A Nationwide, Long-Time, Prospective Follow-Up.Assessment of bone mineral density by dual energy x-ray absorptiometry in patients with mucopolysaccharidoses Enzyme therapy in Fabry disease: severe adverse events associated with anti-agalsidase cross-reactive IgG antibodies.Potential role of vitamin D deficiency on Fabry cardiomyopathy.Ophthalmic experience over 10 years in an observational nationwide Danish cohort of Fabry patients with access to enzyme replacement.Successful salvage therapy with Daptomycin for osteomyelitis caused by methicillin-resistant Staphylococcus aureus in a renal transplant recipient with Fabry-Anderson disease.Bone and joint involvement in Fabry disease.Awareness of Fabry disease among rheumatologists--current status and perspectives.The Influence of Patient-Reported Joint Manifestations on Quality of Life in Fabry Patients.Fabry disease

P2860

Q34311272-8A5C4E4B-DE29-415D-B76C-8B3B75494E5A Q34560222-916EFE17-B109-4AF1-BF0A-1B297DB4AAF8 Q35858698-5CD34B0D-A21C-4429-9C6E-D82F8C7EB4BC Q36972323-27EB8781-0109-4647-AA48-3B5BC160E03A Q37471114-154F42AD-CFA3-4C75-A373-9BB966D68BAE Q37686030-A321751A-EFD0-4458-8596-6D1F63E32334 Q41714642-F98C1479-6D07-414C-8AB7-FBB00021BBF5 Q41858729-AD354E75-891E-4C08-8894-2E7D1CC9E156 Q42642413-538A1994-C021-4A20-A917-EF8602FC2145 Q43676704-9D6425F2-C5FB-4375-9C01-1237A2AF2A34 Q47548176-DD88179C-1A62-4685-81CD-3077BE2FB214 Q56905945-85A65B3A-2348-4D03-BE31-4A0153CA6990

P2860

Osteopenia: a common aspect of Fabry disease. Predictors of bone mineral density.

http://www.wikidata.org/entity/Q46842600

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh

2007年學術文章

@zh-hant

name

Osteopenia: a common aspect of Fabry disease. Predictors of bone mineral density.

@en

Osteopenia: a common aspect of Fabry disease. Predictors of bone mineral density.

@nl

type

label

Osteopenia: a common aspect of Fabry disease. Predictors of bone mineral density.

@en

Osteopenia: a common aspect of Fabry disease. Predictors of bone mineral density.

@nl

prefLabel

Osteopenia: a common aspect of Fabry disease. Predictors of bone mineral density.

@en

Osteopenia: a common aspect of Fabry disease. Predictors of bone mineral density.

@nl

P1433

Q46842600-7FD784B0-9767-4435-A50C-0098F042906D

P1476

Q46842600-5F2E4312-8A25-4C20-AFD0-F78C51F26ED6

P2093

Q46842600-10EFE607-ABAA-4FA9-8BA9-17EDAEC17385

Q46842600-1420F75C-FE15-472B-8EAF-5783A9BB9DEE

Q46842600-1B587743-33D6-493F-9471-F8C61AAFA52E

Q46842600-73BA8193-8B09-45F6-A47E-DA9CB8222BB4

Q46842600-85E31DD4-9FA3-4ACB-A430-99BBF9388A8E

Q46842600-87C9C7FF-EE8E-4D6F-B454-C1E377D16633

Q46842600-A9076228-1783-4721-A41D-EFEE9FB42619

Q46842600-E49DBE52-9C0B-4725-90E4-3C6B3831F2E5

Q46842600-EC633BF5-454B-483E-96D1-BD423A411BAD

P2860

Q46842600-009D68C5-95FA-4340-BCB0-4C4440CE6672

Q46842600-0496D532-E599-4249-98FB-7938B22A6137

Q46842600-0FC4B5FF-70A6-429C-84AC-A8671FCBE9EB

Q46842600-2F77682C-F52A-4A10-B3AE-1FD02CBDAA02

Q46842600-30DE3A6D-E4EF-4DA2-9713-9EDAAEAA10CE

Q46842600-4DE31C34-CAE2-493B-8A52-14014B0D0749

Q46842600-6496F81F-3398-410A-B80B-435236286AB8

Q46842600-6F3AF9C1-4730-426F-B950-210D78A86BDD

Q46842600-7B4507E5-B03A-41B0-9427-1DD2506558C6

Q46842600-80B2DAD4-29A8-4AC5-BB45-445AA0F3D88A

P2888

Q46842600-D010830C-1B84-4C99-B4AC-20A482F3B980

P304

Q46842600-620D9351-A694-4646-A20E-356622B09CD7

P31

Q46842600-0CD316C5-355C-4F62-AF86-46E5081E16CA

P356

Q46842600-78B62754-7E98-45EE-80E8-224D8A5BF02B

P407

Q46842600-FA72A37E-46B6-446A-83D3-79FF51743991

P433

Q46842600-B1FC0BEE-8495-4D6A-A22F-A84DA2513C9A

P478

Q46842600-939C2167-A147-46A3-BF7B-F7EB843FF458

P577

Q46842600-B9E2B0E6-4293-4ADF-83FF-22900C47FF34

P5875

Q46842600-DB67A01A-4D3E-4F71-B6C5-0780070E49F1

P6179

Q46842600-D5C1F8A1-38B6-4A3A-B485-F6352E5D11CC

P698

Q46842600-1DADF4E4-1B86-4240-89EF-35E042FE1DDD

P356

GIM.0B013E31815CB197

P1433

Genetics in Medicine

P1476

Osteopenia: a common aspect of Fabry disease. Predictors of bone mineral density.

@en

P2093

Ase Krogh Rasmussen

http://www.w3.org/2001/XMLSchema#string

Bengt-Ake Bengtsson

http://www.w3.org/2001/XMLSchema#string

Henriette Mersebach

http://www.w3.org/2001/XMLSchema#string

Jan-Ove Johansson

http://www.w3.org/2001/XMLSchema#string

Kirsten Rosenberg

http://www.w3.org/2001/XMLSchema#string

Lis Hasholt

http://www.w3.org/2001/XMLSchema#string

Sven Asger Sørensen

http://www.w3.org/2001/XMLSchema#string

Søren Schwartz Sørensen

http://www.w3.org/2001/XMLSchema#string

Ulla Feldt-Rasmussen

http://www.w3.org/2001/XMLSchema#string

P2860

A phase 1/2 clinical trial of enzyme replacement in fabry disease: pharmacokinetic, substrate clearance, and safety studies

Infusion of alpha-galactosidase A reduces tissue globotriaosylceramide storage in patients with Fabry disease.

Enzyme replacement therapy in Fabry disease: a randomized controlled trial.

Response of Gaucher bone disease to enzyme replacement therapy.

Nervous system involvement in Fabry's disease: clinicopathological and biochemical correlation.

Bone mineral density, biochemical markers and skeletal fractures in haemodialysis patients.

Eye findings in the diagnosis of Fabry's disease. Patients with renal failure.

The ocular manifestations in Fabry's disease.

Central retinal artery occlusion complicating Fabry's disease.

Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry's disease.

P2888

gim.0b013e31815cb197

P304

812-818

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/GIM.0B013E31815CB197

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2007-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5758309

http://www.w3.org/2001/XMLSchema#string

P6179

1005353253

http://www.w3.org/2001/XMLSchema#string

P698

18091430

http://www.w3.org/2001/XMLSchema#string